Hello! here's my question. If the traditional company structure used by pharmaceutical firms, typically

Hello! here's my question. If the traditional company structure used by pharmaceutical firms, typically

functional, product, or matrix structures, haven’t been successful at encouraging drug development, are there nontraditional organizational structures that company could use to do so that can also help to speed development and lower costs?